Colorectal Cancer Market Positioned for Extraordinary Expansion During the Forecast Period (2023-32) - Asserts DelveInsight | Mirati, Exelixis, Enterome, Arcus Biosciences, Lyell Immunopharma, AstraZeneca, Novartis, Surgimab, Numab, SOTIO Biotech, Amgen

As per DelveInsight, the Colorectal Cancer Market is anticipated to evolve immensely in the coming years owing to the rise in the number of incident cases and expected approval of multiple emerging therapies.

DelveInsight's "Colorectal Cancer Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Colorectal Cancer Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Colorectal Cancer therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Colorectal Cancer treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Colorectal Cancer: An Overview
Colorectal cancer (CRC) is the third most common type of cancer, with metastasis being the major cause of death in most patients. CRC usually begins as a polyp that develops in the inner lining of the colon and grows and converts slowly over several years. Once cancer develops, it can grow further into the walls of the colon
and go on to invade blood or lymph vessels.

Often, the cause of CRC is not known. Generally, most CRCs (95%) are considered sporadic, meaning the genetic changes develop by chance after a person is born, so there is no risk of passing these genetic changes on to one's children. Inherited CRCs are less common (5%) and occur when gene mutations, or changes, are passed within a family from one generation to the next (Lynch syndrome).

After someone is diagnosed with CRC, staging is done to determine if it has spread and how far. CRC can be divided into localized, regional, distant, and unknown based on CRC staging. The majority of the patients are diagnosed at the localized or regional stage. Approximately 20% of patients are diagnosed at the metastatic stage.

Colorectal Cancer Market Key Facts
• In 2022, the total incidence cases of CRC were around 546,000 cases in the 7MM.
• In the 7MM, the highest number of incident cases of CRC was observed in the US, with approximately 151,000 cases in 2022.
• In the 7MM, the highest number of incident cases of CRC was observed in the US, with approximately 151,000 cases in 2022.
• In EU4 and the UK, the incident cases of mCRC were around 107,000 in 2022, with the highest cases reported in Germany.
• Globally, CRC is the third most commonly diagnosed cance in males and the second in females, with 1.9 million new cases and almost 935,000 deaths in 2020, according to the World Health Organization Global Cancer Observatory (GLOBOCAN) database.
• As per Xi (2021), CRC is the third leading cause of cancer-related deaths in both genders worldwide, with estimated ~515,600 deaths among males and ~419,500 deaths among females in 2020. More than 5.25 million (5-year prevalence) people worldwide live with CRC, less than breast cancer, which causes 7.79 million cancer cases.

Discover How Colorectal Cancer Market Will Grow by 2032:
https://www.delveinsight.com/report-store/colorectal-cancer-crc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Colorectal Cancer Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Colorectal Cancer therapies in the market. It also provides a detailed assessment of the Colorectal Cancer market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Colorectal Cancer drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Colorectal Cancer Epidemiology
The epidemiology section covers detailed insights into the historical, and current Colorectal Cancer patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Colorectal Cancer Epidemiology Segmented as -
• Incident Cases of CRC in the 7MM [2019-2032]
• Tumor localization-specific Diagnosed Incidence of CRC in the 7MM [2019-2032]
• Gender-specific Diagnosed Incidence of CRC in the 7MM [2019-2032]
• Stage-specific Diagnosed Incidence of CRC in the 7MM [2019-2032]
• Mutation-specific Distribution of CRC in the 7MM [2019-2032]
• Treated cases by line of therapies of CRC in the 7MM [2019-2032]
• Age-specific Diagnosed Incidence of CRC in the 7MM [2019-2032]

Get Key Insights Into the Evolving Colorectal Cancer Epidemiology Trends:
https://www.delveinsight.com/report-store/colorectal-cancer-crc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Colorectal Cancer Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Colorectal Cancer market or expected to be launched during the study period. The analysis covers the market share by Colorectal Cancer drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Colorectal Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/colorectal-cancer-crc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Colorectal Cancer Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Colorectal Cancer. Currently, Mirati Therapeutics is leading the therapeutics market with its Colorectal Cancer drug candidates in the most advanced stage of clinical development. The market space of mCRC would be benefitted in the coming years with the launch of several emerging pipeline therapies.

Leading Companies in the Colorectal Cancer Therapeutics Market Include Mirati Therapeutics, Exelixis, Enterome, Arcus Biosciences, Lyell Immunopharma, AstraZeneca, Novartis Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical, Bristol-Myers Squibb, NGM Biopharmaceuticals, Takeda, PureTech, Pfizer, Kezar Life Sciences, Salubris Biotherapeutics, and many others.

Emerging and Marketed Colorectal Cancer Therapies Covered in the Report Include
• Adagrasib: Mirati Therapeutics
• XL092: Exelixis
• EO2040: Enterome
• Etrumadenant: Arcus Biosciences
• LYL845: Lyell Immunopharma
And Many More

Learn More About the Emerging Therapies & Key Companies in the Colorectal Cancer Therapeutics Market:
https://www.delveinsight.com/sample-request/colorectal-cancer-crc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Colorectal Cancer Competitive Intelligence Analysis
4. Colorectal Cancer Market Overview at a Glance
5. Colorectal Cancer Background and Overview
6. Colorectal Cancer Patient Journey
7. Colorectal Cancer Epidemiology and Patient Population
8. Colorectal Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Colorectal Cancer Unmet Needs
10. Key Endpoints of Colorectal Cancer Treatment
11. Colorectal Cancer Marketed Products
12. Colorectal Cancer Emerging Therapies
13. Colorectal Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Colorectal Cancer Market Outlook (7 major markets)
16. Colorectal Cancer Access and Reimbursement Overview
17. KOL Views on the Colorectal Cancer Market.
18. Colorectal Cancer Market Drivers
19. Colorectal Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/colorectal-cancer-crc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
Radiofrequency Ablation Devices Market
https://www.delveinsight.com/report-store/radiofrequency-ablation-devices-market

Smart Inhalers Market
https://www.delveinsight.com/report-store/smart-inhalers-market

Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market

Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market

Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

Structural Heart Devices Global Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market

Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market

Desmoplastic Small Round Cell Tumors (dsrcts) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market

Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market

Deep Brain Stimulation Devices Market
https://www.delveinsight.com/report-store/deep-brain-stimulation-devices-market

Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.